Genome Editing and Gene Therapy to Treat Angiogenesis

New developments have the potential to change the way retina specialists treat disease.

By Michael J. Ammar, MD, Julia A. Haller, MD

Choroidal Melanoma or Peripheral Exudative Hemorrhagic Chorioretinopathy

Imaging is critical to this diagnostic dilemma.

By Guneet S. Sodhi, MD, Brittney Statler, MD, Arun D. Singh, MD

Pearls for Pediatric Retinal Diseases

Five pearls for five diseases.

By Luis A. Acaba-Berrocal, MD, R.V. Paul Chan, MD, MSc, MBA, FACS, Audina M. Berrocal, MD

A 2020 Update on Vitrectomy Systems

Retina specialist users discuss their experience with various platforms.

By BRIAN JOONDEPH, MD, MPS, FACS, Martin Charles, MD, Dina Abulon, MS, et al.

Cryopreserved Amniotic Membrane for Intravitreal Injection

Take steps to ease injection-associated stress and boost adherence.

By Atul Jain, MD

A Current Perspective on Intraocular Pressure Elevation in Chronic Noninfectious Uveitis

Monitoring protocols are key to preserving vision.

By Michael A. Singer, MD

OpRegen Cell Therapy Has Positive Data in Geographic Atrophy

Visual acuity gains were maintained up to 24 months.

By Jerry Helzner, contributing editor

Gemini Geographic Atrophy Drug to Advance Into Phase 2 Trial

Recombinant form of complement factor H met phase 1 endpoints.

By Jerry Helzner, contributing editor

Wet AMD Patients Prefer PDS Implant Over Injections

Patients underwent only 2 procedures in 40 weeks.

By Jerry Helzner, contributing editor

Suprachoroidal Drug Delivery Scores Well in Study

Physician users report the administration technique to be applicable to a range of anatomic and demographic variables.

By Jerry Helzner, contributing editor

IRIS Registry Study Shows Severe Impact of Geographic Atrophy

Data show that vision loss is often dramatic.

By Jerry Helzner, contributing editor

Adverum Gene-derived Anti-VEGF Proves Highly Durable

Wet AMD patient goes 92 weeks without retreatment.

By Jerry Helzner, contributing editor

SUBSPECIALTY NEWS: Bausch Health takes option for Allegro, phase 3 trials begin for KSI-301, and more.

By Jerry Helzner, contributing editor

UPFRONT: Gene Editing for Retina Is Approaching

By Peter K. Kaiser, MD

FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina

By Jerry Helzner, contributing editor

CLINICAL TRIAL DOWNLOAD: Macular Atrophy Lesion Change With an Anti-VEGF Implant

Retina specialists discuss an analysis of LADDER trial data.

By Yasha Modi, MD , Nitish Mehta, MD, Michael A. Singer, MD, et al.

NEW PRODUCT APPLICATIONS: Artificial Intelligence Brings DR Screening Beyond Eye-Care Practices

A new device achieves autonomous detection of vision-threatening diabetic retinopathy.

CODING Q&A: The Whys and Whens of Billing for Screening Tests

The intent governs the designation of screening or medical necessity.

By Suzanne L. Corcoran, COE

CLINICAL TRIAL UPDATE

The Retina Counselor

Emerging treatments for diabetic eye diseases

By Avni Finn, MD, MBA, Mrinali Gupta, MD

Future Therapies in Uveitis

Novel methods are growing the armamentarium for treating this complex ocular disease.

By Jordan D. Deaner, MD, Sumit Sharma, MD